Literature DB >> 24313391

Risk-adapted strategy partial liver irradiation for the treatment of large volume metastatic liver disease.

Katharine L Aitken1, Diana M Tait, Christopher M Nutting, Komel Khabra, Maria A Hawkins.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24313391     DOI： 10.3109/0284186X.2013.862595

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

1.  Test the Effectiveness of Quantitative Linear-Quadratic-Based (qLQB) Model on Evaluating Irradiation-Induced Liver Injury (ILI) Against Normal Tissue Complication Probability (NTCP).

Authors:  Han Bai; Li Wang; Wenhui Li; Xuhong Liu; Yaoxiong Xia; Li Chang
Journal:  Dose Response       Date:  2020-09-22       Impact factor: 2.658

2.  Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review.

Authors:  Cuauhtémoc de la Peña; María F Gonzalez; César González; Joel M Salazar; Benjamín Cruz
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-23

3.  Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience.

Authors:  Hussam Hijazi; Marie-Pierre Campeau; David Roberge; David Donath; Real Lapointe; Franck Vandenbroucke-Menu; Daniel Taussky; Karim Boudam; Gabriel Chan; Alexis Bujold; Guila Delouya
Journal:  Cureus       Date:  2016-12-20

4.  Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors.

Authors:  Yu Jin Cha; Mi-Sook Kim; Won-Il Jang; Young Seok Seo; Chul Koo Cho; Hyung Jun Yoo; Eun Kyung Paik
Journal:  Radiat Oncol J       Date:  2017-06-30

5.  Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival.

Authors:  Theresa Voglhuber; Kerstin A Eitz; Markus Oechsner; Marco M E Vogel; Stephanie E Combs
Journal:  BMC Cancer       Date:  2021-07-06       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.